nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—CYP3A4—Fingolimod—multiple sclerosis	0.175	0.246	CbGbCtD
Tofisopam—CYP3A4—Methylprednisolone—multiple sclerosis	0.113	0.158	CbGbCtD
Tofisopam—CYP3A4—Triamcinolone—multiple sclerosis	0.0855	0.12	CbGbCtD
Tofisopam—CYP3A4—Mitoxantrone—multiple sclerosis	0.0823	0.116	CbGbCtD
Tofisopam—CYP3A4—Betamethasone—multiple sclerosis	0.0733	0.103	CbGbCtD
Tofisopam—CYP3A4—Prednisolone—multiple sclerosis	0.0724	0.102	CbGbCtD
Tofisopam—CYP3A4—Prednisone—multiple sclerosis	0.0683	0.096	CbGbCtD
Tofisopam—CYP3A4—Dexamethasone—multiple sclerosis	0.0427	0.0599	CbGbCtD
Tofisopam—PDE2A—medulla oblongata—multiple sclerosis	0.00828	0.0981	CbGeAlD
Tofisopam—PDE2A—midbrain—multiple sclerosis	0.00757	0.0896	CbGeAlD
Tofisopam—PDE2A—spinal cord—multiple sclerosis	0.00738	0.0874	CbGeAlD
Tofisopam—PDE10A—nervous system—multiple sclerosis	0.00622	0.0737	CbGeAlD
Tofisopam—PDE2A—nervous system—multiple sclerosis	0.00622	0.0737	CbGeAlD
Tofisopam—PDE10A—central nervous system—multiple sclerosis	0.00599	0.0709	CbGeAlD
Tofisopam—PDE2A—central nervous system—multiple sclerosis	0.00599	0.0709	CbGeAlD
Tofisopam—PDE10A—cerebellum—multiple sclerosis	0.00585	0.0693	CbGeAlD
Tofisopam—PDE2A—cerebellum—multiple sclerosis	0.00585	0.0693	CbGeAlD
Tofisopam—PDE2A—brain—multiple sclerosis	0.00475	0.0563	CbGeAlD
Tofisopam—PDE10A—brain—multiple sclerosis	0.00475	0.0563	CbGeAlD
Tofisopam—PDE4A—cerebellum—multiple sclerosis	0.00403	0.0477	CbGeAlD
Tofisopam—PDE3A—cerebellum—multiple sclerosis	0.00333	0.0395	CbGeAlD
Tofisopam—PDE4A—brain—multiple sclerosis	0.00327	0.0388	CbGeAlD
Tofisopam—PDE3A—brain—multiple sclerosis	0.00271	0.0321	CbGeAlD
Tofisopam—CYP3A4—nervous system—multiple sclerosis	0.00113	0.0134	CbGeAlD
Tofisopam—CYP3A4—central nervous system—multiple sclerosis	0.00109	0.0129	CbGeAlD
Tofisopam—PDE2A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000658	0.00323	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—RGS1—multiple sclerosis	0.000651	0.0032	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000639	0.00314	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RGS1—multiple sclerosis	0.000634	0.00312	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—ALB—multiple sclerosis	0.000633	0.00311	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—RGS1—multiple sclerosis	0.000633	0.00311	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000624	0.00307	CbGpPWpGaD
Tofisopam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000623	0.00306	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000621	0.00305	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000621	0.00305	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—GPR65—multiple sclerosis	0.000617	0.00303	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000617	0.00303	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CNR1—multiple sclerosis	0.00061	0.003	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000604	0.00297	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000604	0.00297	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—GPR65—multiple sclerosis	0.000601	0.00296	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—GPR65—multiple sclerosis	0.0006	0.00295	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CCR2—multiple sclerosis	0.0006	0.00295	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—LINGO1—multiple sclerosis	0.000596	0.00293	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—LINGO1—multiple sclerosis	0.00058	0.00285	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ITGA4—multiple sclerosis	0.000573	0.00282	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IFNB1—multiple sclerosis	0.000569	0.0028	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CCL5—multiple sclerosis	0.000566	0.00278	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCR1—multiple sclerosis	0.000564	0.00277	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000564	0.00277	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000562	0.00276	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CNR1—multiple sclerosis	0.000554	0.00272	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000554	0.00272	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CXCL13—multiple sclerosis	0.00055	0.0027	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCR1—multiple sclerosis	0.00055	0.0027	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000549	0.0027	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000549	0.0027	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCR1—multiple sclerosis	0.000549	0.0027	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000521	0.00256	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000521	0.00256	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TAGAP—multiple sclerosis	0.000517	0.00254	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCL3—multiple sclerosis	0.000517	0.00254	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—IL2—multiple sclerosis	0.000514	0.00253	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000514	0.00253	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000514	0.00253	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CCR5—multiple sclerosis	0.00051	0.00251	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TAGAP—multiple sclerosis	0.000503	0.00247	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000503	0.00247	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000499	0.00245	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PTGER4—multiple sclerosis	0.000498	0.00245	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PGR—multiple sclerosis	0.00049	0.00241	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CXCR3—multiple sclerosis	0.000481	0.00236	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—ALB—multiple sclerosis	0.00048	0.00236	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CD28—multiple sclerosis	0.000476	0.00234	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000473	0.00232	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCR2—multiple sclerosis	0.000468	0.0023	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—S1PR1—multiple sclerosis	0.000452	0.00222	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—S1PR1—multiple sclerosis	0.00044	0.00216	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—GPC5—multiple sclerosis	0.00044	0.00216	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—POMC—multiple sclerosis	0.000439	0.00216	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CNR1—multiple sclerosis	0.000432	0.00212	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CCL5—multiple sclerosis	0.000429	0.00211	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—GPC5—multiple sclerosis	0.000428	0.0021	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000426	0.0021	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000426	0.00209	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00042	0.00206	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000414	0.00204	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000412	0.00202	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCL3—multiple sclerosis	0.000402	0.00198	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TGFB1—multiple sclerosis	0.000401	0.00197	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CCR2—multiple sclerosis	0.0004	0.00197	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.0004	0.00197	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—POMC—multiple sclerosis	0.000399	0.00196	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—MAPK1—multiple sclerosis	0.000393	0.00193	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCL3—multiple sclerosis	0.000392	0.00193	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IL2RA—multiple sclerosis	0.000391	0.00192	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCL3—multiple sclerosis	0.000391	0.00192	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CCL2—multiple sclerosis	0.00039	0.00192	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000389	0.00191	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IL2—multiple sclerosis	0.000389	0.00191	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CXCL10—multiple sclerosis	0.000389	0.00191	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000387	0.0019	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CCR5—multiple sclerosis	0.000387	0.0019	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RGS1—multiple sclerosis	0.000384	0.00189	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000381	0.00187	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PTGER4—multiple sclerosis	0.000377	0.00186	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000376	0.00185	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RGS1—multiple sclerosis	0.000374	0.00184	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000374	0.00184	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PGR—multiple sclerosis	0.000372	0.00183	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000369	0.00182	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—GPR65—multiple sclerosis	0.000364	0.00179	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CXCR3—multiple sclerosis	0.000364	0.00179	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCR2—multiple sclerosis	0.000364	0.00179	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000364	0.00179	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CD28—multiple sclerosis	0.000361	0.00177	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000359	0.00177	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—GPR65—multiple sclerosis	0.000354	0.00174	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCR2—multiple sclerosis	0.000354	0.00174	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—TYK2—multiple sclerosis	0.000354	0.00174	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCR2—multiple sclerosis	0.000354	0.00174	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CD86—multiple sclerosis	0.00034	0.00167	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CNR1—multiple sclerosis	0.000335	0.00165	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCL5—multiple sclerosis	0.000335	0.00164	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CXCL13—multiple sclerosis	0.000333	0.00164	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCR1—multiple sclerosis	0.000333	0.00164	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—POMC—multiple sclerosis	0.000333	0.00164	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000333	0.00164	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CNR1—multiple sclerosis	0.000327	0.00161	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CNR1—multiple sclerosis	0.000326	0.0016	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—IL2—multiple sclerosis	0.000325	0.0016	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCR1—multiple sclerosis	0.000324	0.00159	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CXCL13—multiple sclerosis	0.000324	0.00159	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000324	0.00159	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SPP1—multiple sclerosis	0.00031	0.00152	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TGFB1—multiple sclerosis	0.000304	0.00149	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—POMC—multiple sclerosis	0.000302	0.00149	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000302	0.00149	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCR5—multiple sclerosis	0.000301	0.00148	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—MAPK1—multiple sclerosis	0.000298	0.00146	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL2RA—multiple sclerosis	0.000297	0.00146	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CCL2—multiple sclerosis	0.000296	0.00145	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL2—multiple sclerosis	0.000295	0.00145	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CXCL10—multiple sclerosis	0.000295	0.00145	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000294	0.00144	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000286	0.00141	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—ALB—multiple sclerosis	0.000283	0.00139	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000279	0.00137	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—APOE—multiple sclerosis	0.000274	0.00135	CbGpPWpGaD
Tofisopam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000272	0.00134	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—TYK2—multiple sclerosis	0.000268	0.00132	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCL5—multiple sclerosis	0.00026	0.00128	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000258	0.00127	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CD86—multiple sclerosis	0.000258	0.00127	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000254	0.00125	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCL5—multiple sclerosis	0.000254	0.00125	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCL5—multiple sclerosis	0.000253	0.00124	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000251	0.00123	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CD80—multiple sclerosis	0.000248	0.00122	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000247	0.00122	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—IL2—multiple sclerosis	0.000246	0.00121	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCL3—multiple sclerosis	0.000237	0.00117	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—POMC—multiple sclerosis	0.000236	0.00116	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SPP1—multiple sclerosis	0.000235	0.00115	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCR5—multiple sclerosis	0.000234	0.00115	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCL3—multiple sclerosis	0.000231	0.00114	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000231	0.00114	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCL2—multiple sclerosis	0.00023	0.00113	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IL2—multiple sclerosis	0.000229	0.00113	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PTGER4—multiple sclerosis	0.000229	0.00112	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCR5—multiple sclerosis	0.000228	0.00112	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCR5—multiple sclerosis	0.000228	0.00112	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—MAPK1—multiple sclerosis	0.000225	0.00111	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PGR—multiple sclerosis	0.000225	0.00111	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL2RA—multiple sclerosis	0.000225	0.00111	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000225	0.0011	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL2—multiple sclerosis	0.000223	0.0011	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PTGER4—multiple sclerosis	0.000222	0.00109	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CXCR3—multiple sclerosis	0.000221	0.00109	CbGpPWpGaD
Tofisopam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00022	0.00108	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PGR—multiple sclerosis	0.000219	0.00108	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CD28—multiple sclerosis	0.000219	0.00108	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCR2—multiple sclerosis	0.000215	0.00106	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CXCR3—multiple sclerosis	0.000215	0.00106	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CD28—multiple sclerosis	0.000213	0.00105	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TYK2—multiple sclerosis	0.000209	0.00103	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCR2—multiple sclerosis	0.000209	0.00103	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—APOE—multiple sclerosis	0.000208	0.00102	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—POMC—multiple sclerosis	0.000202	0.000991	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CNR1—multiple sclerosis	0.000198	0.000975	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—POMC—multiple sclerosis	0.000196	0.000964	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CNR1—multiple sclerosis	0.000193	0.000948	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CD80—multiple sclerosis	0.000188	0.000924	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—POMC—multiple sclerosis	0.000183	0.0009	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CCL2—multiple sclerosis	0.000179	0.000881	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TGFB1—multiple sclerosis	0.000179	0.00088	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—POMC—multiple sclerosis	0.000179	0.000878	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CXCL10—multiple sclerosis	0.000178	0.000877	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—POMC—multiple sclerosis	0.000178	0.000876	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—MAPK1—multiple sclerosis	0.000175	0.000863	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCL2—multiple sclerosis	0.000175	0.000859	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CCL2—multiple sclerosis	0.000174	0.000857	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL2—multiple sclerosis	0.000174	0.000856	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CXCL10—multiple sclerosis	0.000174	0.000854	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL6—multiple sclerosis	0.000173	0.000852	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—MAPK1—multiple sclerosis	0.000171	0.00084	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MMP9—multiple sclerosis	0.000165	0.00081	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—TYK2—multiple sclerosis	0.000163	0.0008	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TYK2—multiple sclerosis	0.000159	0.00078	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—TYK2—multiple sclerosis	0.000158	0.000778	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CD86—multiple sclerosis	0.000156	0.000767	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCL5—multiple sclerosis	0.000154	0.000755	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CD86—multiple sclerosis	0.000152	0.000746	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCL5—multiple sclerosis	0.000149	0.000735	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—IL2—multiple sclerosis	0.000149	0.000733	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—STAT3—multiple sclerosis	0.000147	0.000721	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—IL2—multiple sclerosis	0.000145	0.000713	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SPP1—multiple sclerosis	0.000142	0.0007	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCR5—multiple sclerosis	0.000138	0.00068	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SPP1—multiple sclerosis	0.000138	0.00068	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL2RA—multiple sclerosis	0.000136	0.000671	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MYC—multiple sclerosis	0.000136	0.00067	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TGFB1—multiple sclerosis	0.000136	0.000668	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL2—multiple sclerosis	0.000135	0.000666	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCR5—multiple sclerosis	0.000135	0.000662	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MAPK1—multiple sclerosis	0.000133	0.000655	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL2RA—multiple sclerosis	0.000133	0.000652	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL2—multiple sclerosis	0.000132	0.000649	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL2—multiple sclerosis	0.000132	0.000647	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL6—multiple sclerosis	0.000131	0.000646	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SRM—multiple sclerosis	0.000126	0.000621	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—APOE—multiple sclerosis	0.000126	0.000619	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MMP9—multiple sclerosis	0.000125	0.000614	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—APOE—multiple sclerosis	0.000122	0.000602	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—POMC—multiple sclerosis	0.000117	0.000576	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CD80—multiple sclerosis	0.000114	0.00056	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—STAT3—multiple sclerosis	0.000111	0.000546	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CD80—multiple sclerosis	0.000111	0.000544	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—POMC—multiple sclerosis	0.000108	0.000532	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCL2—multiple sclerosis	0.000106	0.00052	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—POMC—multiple sclerosis	0.000105	0.000517	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—MAPK1—multiple sclerosis	0.000104	0.000509	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MYC—multiple sclerosis	0.000103	0.000507	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCL2—multiple sclerosis	0.000103	0.000506	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TGFB1—multiple sclerosis	0.000103	0.000506	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL6—multiple sclerosis	0.000102	0.000503	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MAPK1—multiple sclerosis	0.000101	0.000496	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—MAPK1—multiple sclerosis	0.000101	0.000495	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TYK2—multiple sclerosis	9.61e-05	0.000473	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TYK2—multiple sclerosis	9.35e-05	0.00046	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.9e-05	0.000438	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.9e-05	0.000438	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GPC5—multiple sclerosis	8.14e-05	0.0004	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL2—multiple sclerosis	8e-05	0.000393	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL6—multiple sclerosis	7.96e-05	0.000391	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL2—multiple sclerosis	7.78e-05	0.000382	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL6—multiple sclerosis	7.76e-05	0.000381	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL6—multiple sclerosis	7.74e-05	0.000381	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MMP9—multiple sclerosis	7.57e-05	0.000372	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MMP9—multiple sclerosis	7.36e-05	0.000362	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.75e-05	0.000332	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—STAT3—multiple sclerosis	6.73e-05	0.000331	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—STAT3—multiple sclerosis	6.55e-05	0.000322	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MYC—multiple sclerosis	6.25e-05	0.000307	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TGFB1—multiple sclerosis	6.24e-05	0.000307	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MAPK1—multiple sclerosis	6.12e-05	0.000301	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MYC—multiple sclerosis	6.08e-05	0.000299	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TGFB1—multiple sclerosis	6.07e-05	0.000298	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MAPK1—multiple sclerosis	5.95e-05	0.000293	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL6—multiple sclerosis	4.7e-05	0.000231	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL6—multiple sclerosis	4.57e-05	0.000225	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.88e-05	0.000191	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APOE—multiple sclerosis	2.33e-05	0.000115	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—POMC—multiple sclerosis	2e-05	9.85e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALB—multiple sclerosis	1.83e-05	8.98e-05	CbGpPWpGaD
